3D printing of polycaprolactone/bioactive glass composite scaffolds for in situ bone repair

3D printing technology can fabricate customized scaffolds based on patient-derived medical images, so it has attracted much attention in the field of developing bone repair scaffolds. Polycaprolactone (PCL) is a suitable polymer for preparing bone repair scaffolds because of its good biocompatibility, thermal stability, excellent mechanical properties and degradable properties. However, PCL is a bioinert material and cannot induce new bone formation at the defect site. In this study, the bioactive material 58s bioactive glass was mixed into PCL to form PCL/bioactive glass composite material. The results of contact angle showed that the hydrophilicity of the scaffold was significantly enhanced with the increase of bioactive glass content. In vitro experiment results showed that, with the increase of bioactive glass content, cell adhesion and proliferation were enhanced, the expression levels of Runx2 and Collagen I(COL-I) were upregulated. The experimental results of in vivo radial defect repair in rats also showed that the effect of bone repair was improved with the increase of bioactive glass content. In conclusion, PCL customized bone repair scaffold containing 20% bioactive glass has widely potential used in the field of clinical bone repair.     

Poly(ε‐caprolactone) composite scaffolds loaded with gentamicin‐containing β‐tricalcium phosphate/gelatin microspheres for bone tissue engineering applications

In this study, novel poly(ε‐caprolactone) (PCL) composite scaffolds were prepared for bone tissue engineering applications, where gentamicin‐loaded β‐tricalcium phosphate (β‐TCP)/gelatin microspheres were added to PCL. The effects of the amount of β‐TCP/gelatin microspheres added to the PCL scaffold on various properties, such as the gentamicin release rate, biodegradability, morphology, mechanical strength, and pore size distribution, were investigated. A higher amount of filler caused a reduction in the mechanical properties and an increase in the pore size and led to a faster release of gentamicin. Human osteosarcoma cells (Saos‐2) were seeded on the prepared composite scaffolds, and the viability of cells having alkaline phosphatase (ALP) activity was observed for all of the scaffolds after 3 weeks of incubation. Cell proliferation and differentiation enhanced the mechanical strength of the scaffolds. Promising results were obtained for the development of bone cells on the prepared biocompatible, biodegradable, and antimicrobial composite scaffolds. © 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014 , 131, 40110.     

Development of fibrin conjugated chitosan/nano β‐TCP composite scaffolds with improved cell supportive property for bone tissue regeneration

In the present study, an attempt has been made to improve cell supportive property of chitosan/nano beta tri‐calcium phosphate (β‐TCP) composite scaffolds by modification of scaffold surface with fibrin using ethyl‐3‐(3‐dimethylaminopropyl) carbodimide (EDC) as crosslinking agent. The developed fibrin conjugated chitosan/nano β‐TCP composite scaffolds possess desired pore size and porosity in the range of 45–151 µm and 81.4 ± 4.1%, respectively. No significant change in compressive strength of scaffolds was observed before and after fibrin conjugation. The calculated compressive strength of fibrin conjugated and non‐conjugated chitosan/nano β‐TCP scaffolds are 2.71 ± 0.14 MPa and 2.67 ± 0.11 MPa, respectively. Results of cell culture study have further shown an enhanced cell attachment, cell number, proliferation, differentiation, and mineralization on fibrin conjugated chitosan/nano β‐TCP scaffold. The uniform cell distribution over the scaffold surface and cell infiltration into the scaffold pores were assessed by confocal laser scanning microscopy. Furthermore, higher expression of osteogenic specific genes such as bone sialo protein, osteonectin, alkaline phosphatase, and osteocalcin (OC) on fibrin conjugated scaffolds was observed when compared to scaffolds without fibrin. Altogether, results indicate the potentiality of developed fibrin conjugated composite scaffolds for bone tissue engineering applications. © 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015 , 132, 41534.     

Bone Fracture-Treatment Method: Fixing 3D-Printed Polycaprolactone Scaffolds with Hydrogel Type Bone-Derived Extracellular Matrix and β-Tricalcium Phosphate as an Osteogenic Promoter

Bone formation and growth are crucial for treating bone fractures. Improving bone-reconstruction methods using autologous bone and synthetic implants can reduce the recovery time. Here, we investigated three treatments using two different materials, a bone-derived decellularized extracellular matrix (bdECM) and β-tricalcium phosphate (β-TCP), individually and in combination, as osteogenic promoter between bone and 3D-printed polycaprolactone scaffold (6-mm diameter) in rat calvarial defects (8-mm critical diameter). The materials were tested with a human pre-osteoblast cell line (MG63) to determine the effects of the osteogenic promoter on bone formation in vitro. A polycaprolactone (PCL) scaffold with a porous structure was placed at the center of the in vivo rat calvarial defects. The gap between the defective bone and PCL scaffold was filled with each material. Animals were sacrificed four weeks post-implantation, and skull samples were preserved for analysis. The preserved samples were scanned by micro-computed tomography and analyzed histologically to examine the clinical benefits of the materials. The bdECM–β-TCP mixture showed faster bone formation and a lower inflammatory response in the rats. Therefore, our results imply that a bdECM–β-TCP mixture is an ideal osteogenic promoter for treating fractures.     

Morphology,wettability, and mechanical properties of polycaprolactone/hydroxyapatite composite scaffolds with interconnected pore structures fabricated by a mini‐deposition system

A new mini‐deposition system (MDS) was developed to fabricate scaffolds with interconnected pore structures and anatomical geometry for bone tissue engineering. Polycaprolactone/hydroxyapatite (PCL/HA) composites with varying hydroxyapatite (HA) content were adopted to manufacture scaffolds by using MDS with a porosity of 54.6%, a pore size of 716 μm in the x‐y plane, and 116 μm in the z direction. The water uptake ratio and compressive modulus of PCL/HA composite scaffold increase from 8 to 39% and from 26.5 to 49.8 MPa, respectively, as the HA content increases from 0 to 40%. PCL/HA composite scaffolds have better wettability and mechanical properties than pure PCL scaffold. A PCL/HA composite scaffold for mandible bone repair was successfully fabricated with both interconnected pore structures and anatomical shape to demonstrate the versatility of MDS. POLYM. ENG. SCI., 2012. © 2012 Society of Plastics Engineers     

Fabrication and biocompatibility of porously bioactive scaffold of nonstoichiometric apatite and poly(ε‐caprolactone) nanocomposite

Bioactive nanocomposite of nonstoichiometric apatite (ns‐AP) and poly(ε‐caprolactone) (PCL) was synthesized and its porous scaffold was fabricated. The results show that the hydrophilicity and cell attachment ratio on the composite surface improved with the increase of ns‐AP content in PCL. The composite scaffolds with 60 wt % ns‐AP content contained open and interconnected pores ranging in size from 200 to 500 μm and exhibit a porosity of around 80%. In addition, proliferation of MG₆₃ cells on the composite scaffolds significantly increased with the increase of ns‐AP content, and the level of alkaline phosphatase (ALP) activity and nitric oxide (NO) production of the cells cultured on the composite scaffold were higher than that of PCL at 7 days, revealing that the composite scaffolds had excellent in vitro biocompatibility and bioactivity. The composite scaffolds were implanted into rabbit mandible defects, the results suggest that the introduction of ns‐AP into PCL enhanced the efficiency of new bone formation, and the ns‐AP/PCL composite exhibited in vivo good biocompatibility and osteogenesis. © 2009 Wiley Periodicals, Inc. J Appl Polym Sci, 2010     

Biodegradable polycaprolactone/cuttlebone scaffold composite using salt leaching process

We prepared biodegradable polycaprolactone/cuttlebone scaffold composite by salt leaching process. In the first step, a co-continuous blend of biodegradable materials, polycaprolactone (PCL) and cuttlebone (CB), and an amount of sodium chloride salt particles were mixed using a stirrer. Next, the extraction of mineral salts using de-ionized distilled water was performed using a biodegradable PCL/CB scaffold with fully interconnected pores. Finally, the durable morphology of the scaffolds was fabricated by freeze-drying process at ?53 °C for 24 hrs in a vacuum. In addition, the quadrilateral pres ranged from about 250 to 300 ??m in diameter. Scanning electron microscopy (SEM) and mercury intrusion porosimeter techniques were carried out to characterize the pore morphology. By increasing the CB and sodium chloride salt particle content, the number of interconnected pores, material properties, and pore morphology were dramatically changed. The average compressive strengths (load at 50% strain) of the different porous PCL/CB scaffolds were found to decrease from 133 to about 79 (load at 50% strain, gf) with an increase in porosity. The values of the porosity increased as the sodium chloride salt volume fraction increased     

Surface‐modified pliable PDLLA/PCL/β‐TCP scaffolds as a promising delivery system for bone regeneration

Surface‐modified poly(d , l ‐lactide)/polycaprolactone/β‐tricalcium phosphate complex scaffold was fabricated in this study and we hypothesized that pliable and mechanical strong scaffold would be achieved by regulation of ternary compositions; while superficial modification strategy conduced to preserve and controlled‐release of bioactive growth factors. Properties of the composite scaffolds were systematically investigated, including mechanical properties, surface morphology, porosity, wettability, and releasing behavior. Moreover, the representative cytokine, recombinant human bone morphogenetic protein‐2 (rhBMP‐2), was loaded and implanted into muscular pouch of mouse to assess bone formation in vivo. Improved osteogenesis was achieved ascribed to both amplified β‐tricalcium phosphate (β‐TCP) content and retarded initial burst release. Particularly, scaffold doped with hydroxypropyl methylcellulose (HPMC) displayed optimal osteogenic capability. The results indicated that the PDLLA/PCL/β‐TCP complex scaffold along with HPMC‐coating and rhBMP‐2 loading was a promising candidate for bone regeneration. © 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014 , 131, 40951.     

β-TCP scaffold coated with PCL as biodegradable materials for dental applications

Requirements for an ideal scaffold include biocompatibility, biodegradability, mechanical strength and sufficient porosity and pore dimensions. Beta tricalcium phosphate (β-TCP) has competent biocompatibility and biodegradability, but has low mechanical strength because of its porous structure. Polycaprolactone (PCL) is a biodegradable polymer with elastic characteristics and good biocompatibility. In this study, β-TCP/PCL composites were prepared in different ratio and their morphology, phase content, mechanical properties, biodegradation and biocompatibility were investigated. After coating, surfaces of β-TCP scaffolds were covered with the PCL while some of the pores were partially clogged. The compression and bending strength of β-TCP scaffolds were significantly enhanced by PCL coating. The degradation rate of the scaffold in Tris buffer was reduced with higher content of the PCL coating. MTT and ALP assays showed that the osteoblast cells could proliferate and differentiate on PCL coated scaffolds as well as on bare β-TCP scaffolds. Based on the comprehensive analysis achieved in this study, it is concluded that the β-TCP/PCL composite scaffold fabricated with 40% β-TCP and 5% PCL exhibits optimum properties suitable for dental applications.     

Preparation and characterization of Calendula officinalis-loaded PCL/gum arabic nanocomposite scaffolds for wound healing applications

Medicinal plants such as Calendula officinalis (C. officinalis) are commonly used for skin wounds’ treatment. On the other hand, gum arabic (GA) has a lot of potential for use in wound healing because of its unique physio-chemical properties. Wound healing activity of gum arabic (GA) and Calendula officinalis (C. officinalis) along with good mechanical properties of poly (ε-caprolactone) (PCL) can produce a suitable nanofibrous scaffold for skin tissue engineering as well as wound dressing application. In this study, PCL/C. officinalis/GA nanofibrous scaffolds with diameter distribution in the range of 85–290 nm were prepared via electrospinning. Characteristics of the nanofibrous scaffolds, i.e., morphology, scaffold compounds, porosity, mechanical and antibacterial properties, hydrophilicity and degradability in phosphate buffer saline (PBS) were investigated. Cell viability and proliferation of scaffolds were evaluated by MTT [3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide] assay. Results indicated that hydrophilicity of the PCL/C. officinalis/GA scaffolds was higher than the PCL scaffold. The tensile strength and elongation of the PCL/C. officinalis/GA scaffolds were in the range of 2.13–4.41 MPa and 26.37–74.37%, respectively, which are very suitable for skin tissue engineering. The porosity of the scaffolds was higher than 60% and was appropriate for the proliferation of fibroblast cells. The nanocomposite scaffold also showed suitable degradability and antimicrobial activity. Moreover, cell culture indicated that GA and C. officinalis promoted cell attachment and proliferation. It can be concluded that the nanofibrous calendula-loaded PCL/GA scaffolds are well suited for regenerating skin.

     

Tetracycline hydrochloride-containing poly (ε-caprolactone)/poly lactic acid scaffold for bone tissue engineering application: in vitro and in vivo study

In the current study, tetracycline hydrochloride (TCH), an antibiotic against most of the medically relevant bacteria, was incorporated into poly (ε-caprolactone)/poly lactic acid solution in order to develop a composite scaffold with both antibacterial and osteoinductive properties for the repair of infected bone defects. The composite scaffolds were produced from poly (ε-caprolactone) (PCL) and poly lactic acid (PLA) solution (1:1 (w/w)) incorporated with 3, 5, and 10% (w/w) of TCH by thermally induced phase separation technique. The scaffolds were evaluated regarding their morphology, wettability, porosity, degradation, mechanical properties, and cellular response. The scaffold containing 10% of TCH (PCL/PLA/TCH10%) was chosen as the optimum scaffold for further investigation in a rat femoral defect model. The study showed that after eight weeks, the bone formation was relatively higher in PCL/PLA/TCH10%-treated group with completely filled defect when compared with control (PCL/PLA scaffold without TCH). Histopathological evaluation showed that the defect in PCL/PLA/TCH10%-treated group was fully replaced by new bone and connective tissue. Our results provide evidence supporting the possible applicability of TCH-containing scaffolds for successful bone regeneration.     

Assessment of cell proliferation in salt‐leaching using powder (SLUP) scaffolds with penetrated macro‐pores

In this study, a salt‐leaching using powder (SLUP) scaffold with penetrated macropores was proposed to enhance cell proliferation. A SLUP scaffold is a salt‐leaching scaffold with an arbitrary pore configuration. Although SLUP scaffolds have several advantage over traditional salt‐leaching scaffolds, the cell ingrowth might be poor compared with solid freeform fabrication scaffolds, which have well‐interconnected pores. We therefore proposed SLUP scaffolds with penetrated macropores to assist the cell ingrowth. First, polycaprolactone (PCL) powders with a grain size of 63–100 μm and NaCl powders with a grain size of 100–180 μm were prepared. Next, a uniformly perforated mold was fabricated using an rapid prototyping (RP) system. Then, 500‐, 820‐, or 1200‐μm‐diameter needles were inserted into the holes of the RP mold. Subsequently, the mold was filled with a mixed powder of PCL/NaCl (30 : 70 vol %). The mold was then heated in the oven at 100°C for 30 min, and both the needles and the mold were removed from the PCL/NaCl mixture. Then, the PCL/NaCl mixture was soaked in DI water for 24 h to leach out NaCl particles and dried in a vacuum desiccator for 24 h. The porosity of fabricated scaffolds was calculated using a simple equation, and the compressive stiffness was measured using a universal testing machine. Moreover, each scaffold (10 × 10 × 10 mm³) was seeded with 100,000 Saos‐2 cells and cultured for 14 days. The cell proliferation characteristics were assessed using a CCK‐8 assay at 1, 7, and 14 days for comparison with the control scaffolds, that is, the SLUP scaffolds with no penetrated macropores. © 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014 , 131, 40240.     

Surface‐engineered hydroxyapatite nanocrystal/ poly(ε‐caprolactone) hybrid scaffolds for bone tissue engineering

To achieve novel polymer/bioceramic composite scaffolds for use in materials for bone tissue engineering, we prepared organic/inorganic hybrid scaffolds composed of biodegradable poly(ε‐caprolactone) (PCL) and hydroxyapatite (HA), which has excellent biocompatibility with hard tissues and high osteoconductivity and bioactivity. To improve the interactions between the scaffolds and osteoblasts, we focused on surface‐engineered, porous HA/PCL scaffolds that had HA molecules on their surfaces and within them because of the biochemical affinity between the biotin and avidin molecules. The surface modification of HA nanocrystals was performed with two different methods. Using Fourier transform infrared, X‐ray diffraction, and thermogravimetric analysis measurements, we found that surface‐modified HA nanocrystals prepared with an ethylene glycol mediated coupling method showed a higher degree of coupling (%) than those prepared via a direct coupling method. HA/PCL hybrid scaffolds with a well‐controlled porous architecture were fabricated with a gas‐blowing/particle‐leaching process. All HA/PCL scaffold samples exhibited approximately 80–85% porosity. As the HA concentration within the HA/PCL scaffolds increased, the porosity of the HA/PCL scaffolds gradually decreased. The homogeneous immobilization of biotin‐conjugated HA nanocrystals on a three‐dimensional, porous scaffold was observed with confocal microscopy. According to an in vitro cytotoxicity study, all scaffold samples exhibited greater than 80% cell viability, regardless of the HA/PCL composition or preparation method. © 2011 Wiley Periodicals, Inc. J Appl Polym Sci, 2011     

Investigation of mechanical properties of porous composite scaffolds with tailorable degradation kinetics after in vitro degradation using digital image correlation

Tissue engineering combines artificial scaffolds and living cells in order to reconstruct damaged tissues and organs. The biodegradable scaffolds should maintain their mechanical properties during first stages of the regeneration. The aim of this study was to investigate the extent the degradation affects the mechanical stability of novel biodegradable composite scaffolds in relation to their composition. The scaffolds were made using fused deposition modeling. They were composed of ternary composites containing poly(ε‐caprolactone) (PCL), 5 wt% of tricalcium phosphate (TCP) and 5, 15, and 25 wt% of poly(lactide‐co‐glycolide) (PLGA). Scaffolds made of pristine PCL and binary composite PCL–TCP were tested as reference samples. The degradation experiment was carried out in simulated body fluid at 37°C for 12 weeks. Mechanical tests were carried out in a mechanical tester. Strain was measured using digital image correlation and crossbar displacement. Chemical composition had a significant effect on initial mechanical properties and their changes during degradation. The initial apparent Young's modulus of ternary composite scaffolds was two times higher than that of PCL–TCP. Higher PLGA concentration yielded faster decrease of the mechanical properties. At the end of the experiment, there were no significant differences of the modulus among all tested materials although degradation of the ternary composite scaffolds was significantly advanced. POLYM. COMPOS., 38:2402–2410, 2017. © 2015 Society of Plastics Engineers     

Fabrication of LaCl3‐containing nanofiber scaffolds and their application in skin wound healing

Poly(?‐caprolactone) (PCL)/gelatin (GE) nanofiber scaffolds with varying concentrations of lanthanum chloride (LaCl₃, from 0 to 25 mM) were fabricated by electrospinning. The scaffolds were characterized by scanning electron microscopy, contact angle and porosity measurements, mechanical strength tests, and in vitro degradation studies. In vitro cytotoxicity and cell adhesion and proliferation studies were performed to assess the biocompatibility of the scaffolds, and in vivo wound healing studies were conducted to assess scaffold applications in the clinic. All prepared scaffolds were noncytotoxic, and the growth of adipose tissue–derived stem cells on LaCl₃‐containing scaffolds was better than on the pure PCL/GE scaffold. Cell proliferation studies showed the greatest cell growth in the PCL/GE/LaCl₃ scaffolds. Further, in vivo studies proved that the PCL/GE/LaCl₃ scaffolds can promote wound healing. The results suggest that nanofiber scaffolds containing LaCl₃ promote cell proliferation and have good biocompatibility, and thus potential for application in the treatment of skin wounds. © 2018 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2018 , 135, 46672.     

Fabrication and Evaluation of Polycaprolactone–Poly(hydroxybutyrate) or Poly(3‐Hydroxybutyrate‐co‐3‐Hydroxyvalerate) Dual‐Leached Porous Scaffolds for Bone Tissue Engineering Applications

Polycaprolactone (PCL) blend with poly(hydroxybutyrate) (PHB) or poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHBV) dual‐leached scaffolds are prepared by using the solvent casting and salt–polymer‐leaching technique. The blending of the PHB and PHBV in PCL scaffolds results in decreased porosities of the scaffolds, and the water absorption capacities of the scaffolds also decrease. The compressive modulus of the PCL–PHB and PCL–PHBV dual‐leached scaffolds is greatly increased by the blending of PHB or PHBV matrix. An indirect cytotoxicity evaluation of all scaffolds with mouse fibroblastic cells (L929) and mouse calvaria‐derived preosteoblastic cell (MC3T3‐E1) indicates that all dual‐leached scaffolds are posed as nontoxic to cells. Both PCL–PHB and PCL–PHBV dual‐leached scaffolds are supported by the attachment of MC3T3‐E1 at significantly higher levels to tissue culture polystyrene plate (TCPS) and are able to support the proliferation of MC3T3‐E1 at higher levels to that cells on TCPS and PCL scaffolds. For mineralization, cells cultured on surfaces of PCL–PHB and PCL–PHBV dual‐leached scaffolds show higher mineral deposition than on TCPS and PCL scaffold.

     

The inclusion of fetal bovine serum in gelatin/PCL electrospun scaffolds reduces short‐term osmotic stress in HEK 293 cells caused by scaffold components

Components of gelatin/polycaprolactone (PCL) electrospun scaffolds are released to surrounding media and cause osmotic changes that adversely affect cell viability and proliferation. In this study, the physiological properties of gelatin/PCL scaffolds were investigated by qRT‐PCR and by performing cellular studies on HEK 293 cells. Components released from gelatin/PCL scaffolds were found to induce osmotic stress response in these cells. However, osmotic stress was inhibited by adding fetal bovine serum (FBS) to scaffolds. In addition, focal adhesion related genes were found to be up‐regulated in HEK 293 cells on gelatin/PCL/20% FBS scaffolds, and this induced the down‐regulations of cell‐death related genes. Furthermore, the inclusion of 20% FBS improved the viabilities of HEK 293 cells on gelatin/PCL scaffolds. This study indicates that adding FBS to gelatin/PCL scaffolds improves scaffold bio‐affinity. © 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013     

One‐Pot Fabrication of Poly(ε‐Caprolactone)‐Incorporated Bovine Serum Albumin/Calcium Alginate/Hydroxyapatite Nanocomposite Scaffolds by High Internal Phase Emulsion Templates

In this work, the authors report an effective one‐pot method to prepare poly(ε‐caprolactone) (PCL)‐incorporated bovine serum albumin (BSA)/calcium alginate/hydroxyapatite (HAp) nanocomposite (NC) scaffolds by templating oil‐in‐water high internal phase emulsion (HIPE), which includes alginate, BSA, and HAp in water phase and PCL in oil phase. The water phase of HIPEs is solidified to form hydrogels containing emulsion droplets via gelation of alginate induced by Ca²⁺ ions released from HAp. And the prepared hydrogels are freeze‐dried to obtain PCL‐incorporated porous scaffolds. The obtained scaffolds possess interconnected pore structures. Increasing PCL concentration clearly enhances the compressive property and BSA stability, decreases the swelling ratio of scaffolds, which assists in improving the scaffold stability. The anti‐inflammatory drug ibuprofen can be highly efficiently loaded into scaffolds and released in a sustained rate. Furthermore, mouse bone mesenchymal stem cells can successfully proliferate on the scaffolds, proving the biocompatibility of scaffolds. All results show that the PCL‐incorporated NC scaffolds possess promising potentials in tissue engineering application.

     

Assessment of cell proliferation in knitting scaffolds with respect to pore‐size heterogeneity,surface wettability,and surface roughness

In this study, various types of poly(ε‐caprolactone) (PCL) knitting scaffolds were fabricated and analyzed to assess the cell‐culturing characteristics of knitting scaffolds with respect to pore‐size heterogeneity, surface wettability, and surface roughness. First, control knitting scaffolds were fabricated using 150‐µm‐diameter PCL monofilaments. Using chloroform and NaOH, PCL knitting scaffolds with varying roughness, pore‐size heterogeneity, and surface wettability were fabricated. Cell‐culture assessments were performed on these six types of PCL knitting scaffolds. Saos‐2 cells were used for cell assessments and cultured for 14 days on each scaffold. Consequently, heterogeneous pore‐size distribution and high surface wettability were found to enhance cell proliferation in knitting scaffolds. In addition, for highly hydrophobic knitting scaffolds exhibiting water contact angles greater than 110 degrees, smaller surface roughness was found to enhance cell proliferation. According to this study, in the case of knitting scaffold, NaOH‐treated knitting scaffold, without any control for the pore‐size homogenization, could be a candidate as the optimal knitting scaffold. © 2015 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015 , 132, 42566.     

Fabrication and characterization of electrospun PCL/Antheraea pernyi silk fibroin nanofibrous scaffolds

To engineer tissue restoration, it is necessary to provide a bioactive, mechanically robust scaffold. Electrospun poly(ε‐caprolactone) (PCL) nanofiber is a promising biomaterial candidate with excellent mechanical properties, but PCL scaffolds are inert and lack natural cell recognition sites. To overcome this problem we investigated the incorporation of Antheraea pernyi silk fibroin (ASF) containing inherent RGD tripeptides with PCL in electrospinning process. The mixing ratios showed remarkable impact on the properties of hybrid nanofibers. Increasing PCL content significantly enhanced the mechanical properties of nanofibers. In particular, the mechanical properties were remarkably enhanced when PCL content increased from 50 wt% to 70 wt%. Moreover, the biological assays based on endothelial cells showed promoted cell viability when ASF content reached to 30 wt%. The data demonstrated that the nanofiber containing 70% of PCL and 30% of ASF achieved the most balanced performances for integrating the mechanical properties of PCL and the bioactivity of ASF. Furthermore, biomimetic alignment of 70PCL/30ASF nanofibers was achieved, which could support PC12 neuron‐like cell growth and guide neurite outgrowth, providing a potentially useful option for the engineering of oriented tissues. The results show that the PCL/ASF hybrid nanofibers can be considered as a promising candidate for tissue engineering scaffolds. POLYM. ENG. SCI., 57:206–213, 2017. © 2016 Society of Plastics Engineers